| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2009 | US20090137531 Aryl Amide Sphingosine 1- |
| 05/28/2009 | US20090137530 Amine Compound and Use Thereof for Medical Purposes |
| 05/28/2009 | US20090137529 Substituted esters as cannabinoid-1 receptor modulators |
| 05/28/2009 | US20090137528 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/28/2009 | US20090137527 Compositions and methods for modulating immune function |
| 05/28/2009 | US20090137526 Purification Method for Biomaterial |
| 05/28/2009 | US20090137525 Glycosaminoglycan Composition and Method for Treatment and Prevention of Interstitial Cystitis |
| 05/28/2009 | US20090137524 Substituted arylpyrazoles |
| 05/28/2009 | US20090137523 Compositions for External Application, Containing Adenosyl Cobalamin for Improvement of Skin Diseases |
| 05/28/2009 | US20090137522 Pharmaceutical Composition on Basis of Reverse Transcriptase Inhibitor and Meldonium |
| 05/28/2009 | US20090137521 Certain Compounds, Compositions and Methods |
| 05/28/2009 | US20090137520 Cardiovascular disorders such as tachycardia and atrial flutter, angina, myocardial infarction, diabetes, obesity, ischemia; for example 4-[N-({9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-hydroxymethyl)tetrahydrofuran-2-yl]-6-(cyclopentylamino)purin-2-yl}methyl)carbamoyl]benzenesulfonic acid |
| 05/28/2009 | US20090137519 represents phosphodiester or phosphodiester-like internucleotide linkage; for treating allergy, such as allergic rhinitis and asthma, cancer and hepatitis B and hepatitis C infectious diseases |
| 05/28/2009 | US20090137518 Therapeutic Antiangiogenic Endostatin Compositions |
| 05/28/2009 | US20090137517 Sensitizing a cell to cancer treatment by modulating the activity of a nucleic acid encoding rps27l protein |
| 05/28/2009 | US20090137516 Compositions and methods of treating dyslipidemia |
| 05/28/2009 | US20090137515 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137514 Methods and compositions for silencing genes without inducing toxicity |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137510 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137507 RNA INTERFERENCE MEDIATED INHIBITION OF ANGIOPOIETIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137506 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137505 Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same |
| 05/28/2009 | US20090137504 Microrna target site blocking oligos and uses thereof |
| 05/28/2009 | US20090137503 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| 05/28/2009 | US20090137502 Riproximin, a Novel Type II Ribosome-Inactivating Protein and Uses Thereof |
| 05/28/2009 | US20090137501 Resistance Genes |
| 05/28/2009 | US20090137500 Chemically synthesized doubled stranded micro-RNA (miRNA) molecule; nucleic acids with a pyrimidine modification |
| 05/28/2009 | US20090137499 Benzylphenyl glucopyranoside derivative |
| 05/28/2009 | US20090137498 Substituted benzene derivatives or salts thereof |
| 05/28/2009 | US20090137497 Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine |
| 05/28/2009 | US20090137496 Use of Active Ingredients Containing Hydroxystilbene for Preventing and/or Treating Osteoporosis |
| 05/28/2009 | US20090137494 Tumor-activated prodrug compounds and treatment |
| 05/28/2009 | US20090137491 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137490 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137489 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137488 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137487 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137486 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137482 Biologically active peptide and agent containing the same |
| 05/28/2009 | US20090137473 Inhibition of microtubule protrusion in cancer cells |
| 05/28/2009 | US20090137470 Methods of treating cancer using notch pathway inhibitors |
| 05/28/2009 | US20090137463 Treatment for Neurodegeneration |
| 05/28/2009 | US20090137461 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137457 Pyrimidinedione derivatives |
| 05/28/2009 | US20090137453 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof |
| 05/28/2009 | US20090137451 Methods for Assessing Suitability of Cancer Patients for Treatment with Histone Deacetylase Inhibitors |
| 05/28/2009 | US20090137393 2,4,6-trialkylphenyl substituted cyclopentane-1,3-dione |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090137021 Anti-inflammatory medicaments |
| 05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 05/28/2009 | US20090136980 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 05/28/2009 | US20090136961 Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancer |
| 05/28/2009 | US20090136598 Compositions for the Treatment and Prevention of Eyelid Swelling |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136593 Mazindol combination in the treatment of attention deficit/hyperactivity |
| 05/28/2009 | US20090136592 Vitamin preparation |
| 05/28/2009 | US20090136591 Metallothionein as an early biomarker for death secondary to septic shock and as a novel therapeutic target for septic shock |
| 05/28/2009 | US20090136579 Nanoparticles Comprising a PDGF Receptor Tyrosine Kinase Inhibitor |
| 05/28/2009 | US20090136578 Pharmaceutical Composition Comprising Perindopril or Its Salts |
| 05/28/2009 | US20090136574 Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds |
| 05/28/2009 | US20090136573 Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses Thereof |
| 05/28/2009 | US20090136571 Pharmaceutical formulations containing irbesartan |
| 05/28/2009 | US20090136570 Taste-Masked Tablets and Granules |
| 05/28/2009 | US20090136568 Tabletting process |
| 05/28/2009 | US20090136566 Therapeutic triterpenoids |
| 05/28/2009 | US20090136565 Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R |
| 05/28/2009 | US20090136564 Micelles |
| 05/28/2009 | US20090136561 Non-peptidyl agents with pHSP20-like activity, and uses thereof |
| 05/28/2009 | US20090136558 Anti-Restenosis Coatings and Uses Thereof |
| 05/28/2009 | US20090136555 Process for the preparation of a hot-melt extruded laminate |
| 05/28/2009 | US20090136550 Modified release formulations of diltiazem |
| 05/28/2009 | US20090136549 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
| 05/28/2009 | US20090136544 Interfering RNAs Targeting the Morbillivirus Nucleoprotein Gene |
| 05/28/2009 | US20090136539 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 05/28/2009 | US20090136531 HPV E6 protein T cell epitopes and uses thereof |
| 05/28/2009 | US20090136521 Method for Selectively Depleting Hypoxic Cells |
| 05/28/2009 | US20090136520 Mitochondrial localization of muc1 |
| 05/28/2009 | US20090136517 Combined treatment with an egfr kinase inhibitor and an inhibitor of c-kit |
| 05/28/2009 | US20090136514 Tetracyclines for Treating Ocular Diseases and Disorders |
| 05/28/2009 | US20090136513 Bicyclo-pyrazoles active as kinase inhibitors |
| 05/28/2009 | US20090136512 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136506 Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target |
| 05/28/2009 | US20090136502 Preventives/Remedies for Cancer |
| 05/28/2009 | US20090136499 RAF Inhibitors and Uses Thereof |
| 05/28/2009 | US20090136497 Methods for inhibiting cutaneous inflammation and hyperpigmentation |
| 05/28/2009 | US20090136496 Chronic lymphocytic leukemia prognosis and treatment |
| 05/28/2009 | US20090136489 Methods for the treatment, diagnosis, and prognosis of cancer |
| 05/28/2009 | US20090136487 Bmx mediated signal transduction in irradiated vascular endothelium |
| 05/28/2009 | US20090136482 Drug target protein and target gene, and screening method |
| 05/28/2009 | US20090136481 Use of Myostatin (GDF-8) Antagonists for Treatment of Sarcopenia (Age-Related Muscle-Wasting) |
| 05/28/2009 | US20090136478 Methods for using enzymes to disintegrate cancerous tumors in vivo |